Two very different Alzheimer’s tests just teamed up

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Circular Genomics and Altoida are combining a blood test with a 10-minute cognitive app to catch Alzheimer’s earlier.

Alzheimer’s disease has a timing problem. By the time most patients get a diagnosis, the neurodegeneration behind it has often been building for years, sometimes decades, quietly, before anyone notices a symptom worth mentioning to a doctor. New drugs that target the disease’s underlying biology are starting to reach patients, but those drugs work best early. Diagnosis, unfortunately, still tends to happen late.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

Kyle Umipig

Kyle has nine years of editorial writing experience. They have been following the longevity sector since 2022, focusing on research, emerging tech, and the companies shaping the future of aging and age-related health.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE